Earlier this month a story was posted to CNN's iReport social news site which caused Apple stock to plummet. The stories on that site are not vetted before they are allowed to appear on the site. The story said:

Depression symptoms are associated with significantly higher use of healthcare services following a heart attack, according to a new study released today by the Centre for Addiction and Mental Health (CAMH).

Erectile dysfunction gives a two to three year early warning of a heart attack, warns an expert on bmj.com today.

1 year results from landmark HORIZONS AMI trial: Use of bivalirudin is shown to improve survival compared to standard drug therapy for heart attack patients following angioplasty

Molecular imaging agent reveals beneficial effects of tissue-protecting hormone, according to article in The Journal of Nuclear Medicine

Women, the elderly, and patients admitted to the emergency department on weekends are all less likely to receive same-day coronary angioplasty for a life-threatening heart attack in Florida, University of South Florida researchers found. Their study was published this month in the American Journal of Cardiology.

Statins are powerful drugs that reduce "bad" cholesterol and thus cut the risk of a heart attack. While these medications offer tremendous benefits to millions, they can carry side effects for some. The most frequently reported consequence is fatigue, and about nine percent of patients report statin-related pain.

An Italian study, the first outcome of a large epidemiological investigation, finds new beneficial effects of chocolate in the prevention of cardiovascular disease

Researchers have identified specific damages to the brain that may occur when heart attack victims are socially isolated from others.

Thousands of patients with high blood pressure could benefit from changing their drug treatment regimen to reduce their risk of cardiac death.

Someday doctors may be able to use a blood test to confirm within minutes, instead of hours, if a patient is having a heart attack, allowing more rapid treatment that could limit damage to heart muscle.

Data from a Phase II study of an investigational drug designed to block formation of blood clots show potential for added protection against a second heart attack or stroke among patients who are already taking state-of-the-art prevention therapy, according to researchers at the Duke Clinical Research Institute.